Brief: Xbrane Biopharma - Update On Out-Licensing, Financial Position
12/08/2024 10:44
Aug 12 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* OUT-LICENSING HAS PROVEN MORE DIFFICULT THAN INITIALLY
ENVISIONED BY COMPANY
* CO NEEDS TO FINALIZE ONE OF THE LICENSE DEALS AT
SATISFACTORY
TERMS PRIOR TO END OF OCT 2024 TO FULFILL CO'S WORKING CAPITAL
REQUIREMENTS FROM BEGINNING OF NOV 2024 AND ONWARDS
Source text for Eikon: ID:nMFNblqzmg
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))